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Abstract
The GTPase RhoA participates in a number of cellular processes, including cytoskeletal
organization, mitogenesis and tumorigenesis. We have previously shown that the transforming
activity of an oncogenic version of RhoA (Q63L mutant) was highly dependent on the
transcriptional factor c–Myc. In contrast to these positive effects in the RhoA route, we show here
that c–Myc affects negatively the F–actin cytoskeleton induced by RhoAQ63L and its downstream
effector, the serine/threonine kinase Rock. This effect entails the activation of a transcriptional
program that requires synergistic interactions with RhoA–derived signals and that includes the
upregulation of the GTPase Cdc42 and its downstream element Pak1 as well as the repression of
specific integrin subunits. The negative effects of c–Myc in the F–actin cytoskeleton are
eliminated by the establishment of cell–to–cell contacts, an effect associated with the rescue of
Pak1 and integrin levels at the post–transcriptional and transcriptional levels, respectively. These
results reveal the presence of a hitherto unknown signaling feed–back loop between RhoA and c–
Myc oncogenes that can contribute to maintain fluid cytoskeletal dynamics in cancer cells.
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INTRODUCTION
RhoA is a GTP–binding protein that belongs to the Rho/Rac GTPase subfamily (Bustelo et
al., 2007; Etienne–Manneville & Hall, 2002; Jaffe & Hall, 2005). This protein plays critical
roles in general cell functions such as F–actin cytoskeletal dynamics, mitogenesis and cell
survival as well as in cell type–specific biological processes that include, among others,
arterial contractility, axogenesis and phagocytosis (Bustelo et al., 2007; Etienne–Manneville
& Hall, 2002; Jaffe & Hall, 2005). To carry out those functions, RhoA engages a wide
collection of downstream effectors that work as protein kinases, lipid–related enzymes or
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scaffolding proteins (Bustelo et al., 2007; Jaffe & Hall, 2005). Among those effectors, RockI
and RockII are perhaps the best characterized at the structural, regulatory, and biological
levels (Mueller et al., 2005; Riento & Ridley, 2003). These serine/threonine kinases mediate
the formation of stress fibers and focal adhesions, thereby participating in cell–to–cell and
cell–to–substratum adhesion, cell migration and invasiveness, neurite retraction and
phagocytosis (Mueller et al., 2005; Riento & Ridley, 2003).
In addition to the canonical regulation of RhoA by guanosine nucleotide exchange factors
(GEFs), GTPase activating proteins (GAPs), and Rho GDP dissociation inhibitors
(RhoGDIs) which is common to most Rho/Rac proteins (Bos et al., 2007; Dransart et al.,
2005; Olofsson, 1999), the signaling output of RhoA can be controlled by unique
mechanisms. Those include its proteosomal degradation via the ubiquitin ligase Smurf1
(Sahai et al., 2007; Wang et al., 2006; Wang et al., 2003), the inactivation of Rock proteins
by the binding to either the cell cycle inhibitor p21WAF (Lee & Helfman, 2004) or RhoE,
Gem and Rad GTPases (Hatzoglou et al., 2007; Riento et al., 2003; Ward et al., 2002), and
the stimulation of Rock activity by dephosphorylation by the Shp2 phosphatase (Lee &
Chang, 2008). The signal output from the RhoA route can be also influenced by more distal,
transcriptional–based mechanisms. Hence, it has been shown that the tumor suppressor p53
activates RhoE gene transcription, leading to the inhibition of Rock–dependent effects
(Ongusaha et al., 2006). Proteomic experiments have revealed that c–Myc can regulate the
activity of RhoA–dependent routes by lowering the levels of RhoA, Cdc42, Rock and a
subset of cytoskeletal–related proteins (Shiio et al., 2002). It is important to note that these
regulatory influences are usually bidirectional, a property that facilitates the establishment of
feed–back loops that can provide further plasticity to GTPase–regulated processes.
Consistent with this view, it has been shown that RhoA and Cdc42 can stimulate and repress
c–Myc (Berenjeno et al., 2007; Watnick et al., 2003) and p53 (Park et al., 2009),
respectively. In this work, we present evidence indicating that there exists another cross–talk
between c–Myc and RhoA that contributes to the dowmodulation of the RhoA/Rock
cytoskeleton in mouse fibroblasts. Interestingly, this transcriptional program is inhibited by
the establishment of cell–to–cell contacts both at the transcriptional and posttranslational
level, a property that gives further flexibility to the modulation of F–actin cytoskeletal
dynamics in vivo.
RESULTS
Overexpression of c–Myc leads to the disruption of RhoAQ63L–induced stress fibers and
focal adhesions
During a previous study (Berenjeno et al., 2007), we generated a number of NIH3T3 cell
derivatives expressing RhoAQ63L, c–Myc, RhoAQ63L plus c–Myc, and RhoAQ63L plus
either a c–Myc dominant negative mutant (MadMyc) or a c–Myc–specific short hairpin
RNA (shRNA). Using those cell lines, we demonstrated that c–Myc was important for both
the loss of cell contact inhibition and cell transformation induced by the RhoAQ63L
oncogene in fibroblasts (Berenjeno et al., 2007). To further characterize the effect of the c–
Myc network in the transformation mediated by this GTPase, we decided to check the status
of the F–actin cytoskeleton in these cells using microscopy techniques. As previously
described (Berenjeno et al., 2007), we observed that RhoAQ63L–transformed cells contained
robust stress fibers when compared with the parental cell line (Fig. 1A). However, this
cytoskeletal phenotype was lost in cell lines co–expressing RhoAQ63L and c–Myc (Fig. 1A
and data not shown) but not in those co–expressing RhoAQ63L with either MadMyc (Fig.
1A) or a c–Myc specific shRNA (Fig. 1A). The comparison of parental and c–Myc
expressing NIH3T3 cells indicated that the overexpression of c–Myc alone also induced the
disruption of stress fibers (Fig. 1A). This effect, however, was less conspicuous than that
found in the case of RhoAQ63L–transformed cells because of the lower levels of stress fibers
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present in the parental NIH3T3 cells (Fig. 1A). In agreement with the confocal microscopy
data, we found using flow cytometry experiments that cell lines co–expressing RhoAQ63L
and c–Myc had lower F–actin levels than those expressing exclusively RhoAQ63L (Fig.
1B,C). These analyses also indicated that the co–expression of MadMyc further elevated the
total levels of F–actin induced by RhoAQ63L (Fig. 1B,C), suggesting that the increased
levels of endogenous c–Myc protein induced by RhoAQ63L also contribute to tuning down
the RhoAQ63L–dependent F–actin cytoskeleton in fibroblasts. Western blot experiments
indicated that negative effect of c–Myc in the F–actin cytoskeleton was not due to
alterations in the total amount of actin present in fibroblasts (Fig. 1D).
To extend these observations to other cellular structures, we investigated the status of focal
adhesions and microtubules in those cells lines. The overexpression of c–Myc eliminated the
numerous focal adhesions present in RhoAQ63L–transformed NIH3T3 cells (Fig. 2A,B). The
negative effect of c–Myc overexpression in the RhoAQ63L–dependent F–actin cytoskeleton
was not constitutive, because we observed a restoration of both stress fibers and focal
adhesions when cell lines co–expressing RhoAQ63L and c–Myc established extensive cell–
to–cell contacts (Fig. 2A,B). The effect of c–Myc in the F–actin cytoskeleton was specific,
since it did not have any effect on the microtubule network when overexpressed in either
parental or RhoAQ63L–expressing NIH3T3 cells (Supplementary Fig. 1 available online).
We have also previously demonstrated that cell lines overexpressing RhoAQ63L and c–Myc
are more transforming than those expressing the GTPase alone (Berenjeno et al., 2007).
Consistent with the F–actin–specific inhibitory effect of c–Myc overexpression, we
observed that the overexpression of c–Myc did not antagonize other RhoAQ63L–mediated
responses such as the loss of cell polarity in NIH3T3 cells (Supplementary Fig. 2 available
online). These results indicate that the antagonistic function of c–Myc seems to be limited to
RhoA–dependent cytoskeletal pathways and cannot be generalized to other unrelated
pathways that contribute to cell transformation or cell polarity loss.
c–Myc targets the Rock pathway
Since the formation of stress fibers and focal adhesions by RhoA is regulated by Rock
(Amano et al., 1997; Riento & Ridley, 2003), we next investigated the status of this pathway
in the presence or absence of overexpressed c–Myc. To this end, we evaluated the
phosphorylation levels of two well–known Rock downstream elements, the myosin light
chain (MLC) and the myosin binding subunit of MLC phosphatase (MYPT1) (Fig. 3A)
(Amano et al., 1996; Kimura et al., 1996; Riento & Ridley, 2003). In addition, we evaluated
MLC, MYPT1, RockI and RockII protein levels in the indicated cells (Fig. 3A). Whereas we
did not observe any significant change in the total levels of those four proteins among
RhoAQ63L– and RhoAQ63L/c–Myc expressing cells (Fig. 3B), we found that the
phosphorylation levels of both MLC and MYPT1 were severely decreased in cells co–
expressing RhoAQ63L and c–Myc (Fig. 3B,C), indicating that c–Myc overexpression leads
the inhibition of the Rock pathway in RhoAQ63L–transformed cells. Additional experiments
indicated that the inhibition of Rock signaling was not due to indirect effects in the
membrane localization of RhoAQ63L (data not shown) or to increases in the cytosolic
distribution of p21WAF1 (Fig. 3D), a cell cycle inhibitor that can bind to Rock and inhibit its
catalytic activity (Fig. 3A) (Lee & Helfman, 2004). We could not see either any elevation in
the mRNA levels of RhoE (data not shown, but see below, Fig. 5), a GTPase that inactivates
Rock (Riento et al., 2003). These results indicate that c–Myc affects negatively the activity
of the Rock/MLC pathway in RhoAQ63L–transformed cells.
Given the above results, we next investigated whether an increase in the levels of either
RhoAQ63L or RockII signals could restore the F–actin cytoskeleton in c–Myc– and
RhoAQ63L/c–Myc–expressing NIH3T3 cells. To this end, we transiently expressed in cells
either an enhanced green fluorescent protein (EGFP) fused to RhoAQ63L or a chimeric
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protein composed of EGFP, the RockII kinase domain, and the estrogen receptor hormone
binding domain (EGFP–RockIIKD–ER protein). The latter protein only becomes activated
upon treatment of cells with hydroxytamoxifen (4–OHT) (Croft et al., 2004). The transient
expression of EGFP–RhoAQ63L restored stress fibers in both c–Myc– and RhoAQ63L/c–
Myc–expressing cells (Fig. 4A). Instead, its expression in RhoAQ63L–transformed cells did
not enhance the numerous stress fibers already present in those cells (data not shown). The
EGFP–RockIIKD–ER protein induced the formation of stress fibers in both parental and
RhoAQ63L–expressing NIH3T3 cells when derepressed by 4–OHT binding (Fig. 4B). The
stress fibers induced by the EGFP–RockIIKD–ER chimera showed an aster–like distribution
and not the typical parallel network of F–actin fibers, an effect probably derived from the
lack of activation of other RhoA downstream elements that contribute to proper stress fiber
orientation (i.e., mDia) (Nakano et al., 1999). Similar, radially oriented stress fibers were
also induced by the 4–OHT–stimulated EGFP–RockIIKD–ER in RhoAQ63L/c–Myc–
expressing cells (Fig. 4B). However, in this case the transfected cells spread less efficiently
than parental and RhoAQ63L–expressing NIH3T3 cells (Fig. 4B). The number of stress
fibers per cell induced by the inducible RockII kinase domain was also reduced when
compared to those found in the latter cell lines (Fig. 4B). The cytoskeletal effects of the
EGFP–RockIIKD–ER chimera were due to its kinase activity, as demonstrated by the lack
of stress fiber induction when a catalytically inactive version of this protein was used (Fig.
4B). Taken together, these results suggest that the effect of c–Myc on the F–actin
cytoskeleton is probably mediated by two independent routes, one affecting the total
signaling output of the RhoA/Rock signaling route (which can be recovered by the
overexpression of RhoA or RockII) and another one probably linked to cytoskeletal
components related to spreading and focal adhesions that cannot be fully restored by
enhanced RhoA/Rock signals.
Characterization of the transcriptomal changes induced by the overexpression of c–Myc in
RhoAQ63L–transformed cells
We hypothesized that the negative effects of c–Myc in the F–actin cytoskeleton of
RhoAQ63L–transformed fibroblast had to be transcriptome–based. To identify gene targets
that could be involved in this response, we carried out Affymetrix microarray analysis using
total RNAs obtained from subconfluent cultures of RhoAQ63L–, RhoAQ63L/c–Myc–, and of
RhoAQ63L/MadMyc–expressing cells (Berenjeno et al., 2007). Using the selection criteria
indicated in the Supplemental Materials and Methods Section, we found a total of 535 genes
(239 upregulated, 296 downregulated) whose protein products could be potentially involved
in the negative modulation of the RhoA–dependent F–actin cytoskeleton by c–Myc (Fig. 5A
and Supplementary Table I available online). Of those 535 genes, 152 genes had opposed
expressing profiles between RhoAQ63L/c–Myc– and RhoAQ63L/MadMyc–expressing cells
(Fig. 5A and Supplementary Table I). Functional annotation of the proteins encoded by
those genes indicated that they were involved in a large variety of cellular functions
(Supplementary Table II available online). Most of those proteins did not have any obvious
correlation with cytoskeletal regulatory events or cytoskeletal structures. However, we
found a small subset of c–Myc targeted loci encoding proteins that could be assigned to
three functional categories related to the regulation of cytoskeletal dynamics: (i) Direct
upstream regulators of the RhoA pathway. (ii) GTPases that antagonize RhoA signaling
routes. (iii) Structural elements of the cell cytoskeleton (Fig. 5B and Supplementary Text
available online). Some of those proteins were dismissed since they were unlikely to block
signals derived from the constitutively active version of RhoA expressed in the NIH3T3 cell
lines used in this study (see Supplementary Text). As a consequence, we decided to focus
our attention in the deregulated genes that encoded important cytoskeletal regulators such as
Cdc42, Pak1, and integrin subunits (Itgβ1l, Itgβ5 and Itgα5) (Fig. 5B and Supplementary
Text). To corroborate the microarray data on those genes, we performed quantitative RT–
Sauzeau et al. Page 4
Oncogene. Author manuscript; available in PMC 2011 January 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
PCR experiments. As negative controls, we used oligonucleotide pairs to amplify cDNAs
encoding integrins (β1, β4) not identified in our arrays. In order to maximize the
information gathered from these experiments, we decided to carry out RT–PCR reactions
using total RNAs from subconfluent cultures of c–Myc–, RhoAQ63L–, RhoAQ63L/c–Myc–
and RhoAQ63L/MadMyc– expressing cells. Using this approach, we wished to verify
whether the expression of those genes was dependent exclusively on the expression of c–
Myc or, alternatively, on synergistic interactions between the transcriptional programs of c–
Myc and RhoAQ63L. These experiments indicated that the Cdc42 (Fig. 6A) and Pak1 (Fig.
6B) mRNAs were indeed upregulated in RhoAQ63L/c–Myc–expressing cells when compared
to the rest of cell lines used in the study. The upregulation of Pak1 protein in RhoAQ63L/c–
Myc–expressing NIH3T3 cells was also demonstrated by immunoblot experiments
(Supplementary Figs. 3A and 4A,B). Consistent with the microarray data, we also observed
reduced levels of expression for the Itbl1 (Fig. 6D) and Itgb5 (Fig. 6E) mRNAs but not for
the Itgb4 transcript (Fig. 6F) in RhoAQ63L/c–Myc–expressing NIH3T3 cells. A significant
reduction, not picked up in the microarray experiments, was also observed for the Itgb1
transcript in that cell line (Fig. 6C). This repression was also observed at the protein level in
RhoAQ63L/c–Myc–expressing cells (Supplementary Fig. 3B). Most of the transcript tested
were found differentially expressed at statistical significant levels only in RhoAQ63L/c–
Myc–expressing cells, indicating that they are regulated by synergistic interactions between
RhoAQ63L–dependent signals and c–Myc. Interestingly, the Itgb5 mRNA was the only one
showing a specific variation in RhoAQ63L/MadMyc–expressing cells, suggesting that it may
be one of the key elements promoting the increased numbers in stress fibers observed in this
cell line (see above, Fig. 1A,B).
To get an overall view of the synergistic cross–talk among RhoAQ63L and c–Myc at the
transcriptional level, we next compared the genes identified as “RhoAQ63L/c–Myc specific”
in these experiments with the “RhoAQ63L specific” transcriptome previously described by us
in NIH3T3 cells (Berenjeno et al., 2007). Consistent with expression patterns resulting from
synergistic interactions between RhoAQ63L signals and overexpressed c–Myc protein, we
found that the majority of the deregulated genes present in RhoAQ63L/c–Myc–expressing
cells were not present in the transcriptome of RhoAQ63L–expressing fibroblasts (see further
details in Supplementary Text). Since our previous results indicated that some of the Rock
targets were downmodulated in RhoAQ63L/c–Myc expressing cells (see above, Fig. 3B,C),
we also compared the present microarray data with the previously described Rock/Y27632–
dependent transcriptome of RhoAQ63L–transformed cells (Berenjeno et al., 2007). We
considered that, if c–Myc abrogated all Rock signaling, there had to be a significant overlap
between the Rock/Y27632– and RhoAQ63L/c–Myc–dependent transcriptomes. We found
that c–Myc overexpression only targeted 4.1% of the 97 Rock/Y27632–dependent genes
previously identified as Rock/Y27632–dependent in RhoAQ63L–transformed cells, a result
that further suggest that this transcriptional factor does not abolish all Rock–dependent
functions in fibroblasts. This is consistent with previous data indicating that c–Myc
overexpression, unlike the Y27632 treatments (Berenjeno et al., 2007; Sahai et al., 1999),
does not affect RhoAQ63L transforming activity in NIH3T3 cells (Berenjeno et al., 2007).
Taken together, these results indicate that the overexpression of c–Myc leads to synergistic
interactions with RhoA–dependent signals that result in new patterns of gene expression.
Moreover, they suggest that c–Myc overexpression targets the cytoskeletal signaling branch
of Rock but not other Rock–related functions.
Increased cell densities overturn the upregulation of Pak1 and integrin subunits found in
RhoAQ63L/c–Myc–expressing cells
To further correlate the aforementioned transcriptomal changes with the conditions in which
the cell cytoskeleton is inhibited in RhoAQ63L/c–Myc expressing cells, we evaluated the
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expression of Cdc42, Pak1, Itgb1, Itbl1 and Itgb5 genes in dense cell cultures. Quantitative
RT–PCR experiments revealed that the expression of Cdc42 and Pak1 genes was
independent on the density of RhoAQ63L/c–Myc–expressing cells in culture (Fig. 6, panels
G and H, respectively). Despite this, we observed that the protein levels of Pak1 were
severely diminished in dense cell cultures (Supplementary Fig. 4), suggesting that this
kinase may be controlled by a post–transcriptional mechanism upon the establishment of
cell–cell contacts. The repression of Itgb1, Itgbl1 and Itgb5 genes observed in RhoAQ63L/c–
Myc–expressing cells was totally eliminated when these cells were cultured at increased
densities (Fig. 6, panels I, J and K, respectively). A strong repression of Itgβ1 protein levels
in RhoAQ63L/c–Myc expressing cells, which was rescued in high cell density conditions,
was also demonstrated using Western blot analysis (Supplementary Fig. 3B). These
experiments indicate that a subset of the RhoAQ63L/c–Myc–dependent transcriptome and
proteome can be antagonized by the establishment of cell–to–cell contacts.
Pak1 and integrins contribute to the c–Myc–dependent inhibition of the RhoA–dependent
cytoskeleton
We hypothesized that if some of the above genes were involved in the disassembly of stress
fibers in RhoAQ63L/c–Myc–expressing cells, the manipulation of the levels of activity and/
or expression of their protein products should induce the disruption of the stress fiber
network in RhoAQ63L–expressing cells in the absence of c–Myc overexpression or,
alternatively, rescue the stress fibers defects in RhoAQ63L/c–Myc–expressing cells. To
investigate this possibility, we first analyzed the influence of the Cdc42/Pak1 axis in the
stability of stress fibers in RhoAQ63L–expressing NIH3T3 cells. To this end, we infected
those cells with retroviruses encoding bicistronically the EGFP and different versions of
Cdc42, Rac1, and Pak1 proteins. Those included a fast–cycling mutant (F28L) of Cdc42 that
shows constitutive activity in vivo (Lin et al., 1997), a fast–cycling mutant (F28L) of Rac1
(a GTPase that also binds and activates Pak1) (Guo & Zheng, 2004), a Rac1F28L protein
containing a point mutation in its switch region (F37A) that eliminates the binding and
activation of Pak1 (Joneson et al., 1996), a Rac1F28L protein with a point mutation in the
switch region (Y40C) that retains the ability of stimulating Pak1 (Joneson et al., 1996), and
the wild type version of Pak1. The expression of Cdc42F28L (Fig. 7A, Supplementary Fig.
5A), Rac1F28L+Y40C (Fig. 7A, Supplementary Fig. 5A) and wild type Pak1 (Fig. 7A,B,
Supplementary Fig. 5A,B) led to the disassembly of the F–actin stress fibers in RhoAQ63L–
expressing cells. Instead, and consistent with the implication of Pak1 in this process, the
expression of the Rac1F28L+F37A mutant had no effects on the cytoskeleton of RhoAQ63L–
transformed cells (Fig. 7A, Supplementary Fig. 5A).
To further verify the involvement of Pak1 in the c–Myc–dependent inhibition of the
cytoskeleton, we infected RhoAQ63L–, RhoAQ63L/c–Myc– and RhoAQ63L/MadMyc–
expressing cells with retrovirus encoding bicistronically the EGFP and a dominant negative
Pak1 protein (K298R mutant). The overexpression of that mutant promoted the re–
establishment of stress fibers in cells co–expressing RhoAQ63L and c–Myc, indicating that
the endogenous Pak1 protein does contribute to the downmodulation of their stress fibers
(Fig. 7C, Supplementary Fig. 5C). In agreement with the lack of upregulation of Pak1 in
RhoQ63L– and RhoAQ63L/MadMyc–expressing cells, Pak1K298R did not induce any
significant effect in the stress fibers of those two cell lines (Fig. 7C, Supplementary Fig.
5C). We observed that the inhibitory effect of Pak1 on the stress fiber network was lost
when RhoAQ63L/Pak1–expressing cells established large numbers of cell–to–cell contacts
(Fig. 7D, Supplementary Fig. 5D). These experiments indicate that Pak1 overexpression
mimics the effects of c–Myc overexpression in the F–actin cytoskeleton of RhoAQ63L–
transformed cells.
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We next used siRNAs for Itgb1 and Itgb5 transcripts to investigate the effects of integrin
downmodulation in the stability of stress fibers of RhoAQ63L–expressing NIH3T3 cells. The
knockdown of any of these two integrins induced a ≈50% reduction in the total number and
thickness of stress fibers (Fig. 7E, Supplementary Fig. 5E). As control, we observed that a
siRNA containing a scrambled nucleotide sequence did not affect the stress fibers present in
RhoAQ63L–expressing fibroblasts (Fig. 7E). The knockdown of Itgb1 and Itgb5 mRNAs
induced loss of adherence and the detachment of cells from the coverslip (data not shown).
The knock–down levels of Itgb1 and Itgb5 transcripts were verified by RT–PCR
experiments (Fig. 7E). Taken together, these results demonstrate that Pak1 and integrin
subunits β1 and β5 are integral components of the transcriptional program that eliminates
the RhoA/Rock dependent cytoskeleton in RhoAQ63L/c–Myc–transformed NIH3T3 cells.
c–Myc overexpression changes the invasion and adhesion properties of RhoA–
transformed cells
To verify whether the RhoA/c–Myc cross–talk had any effect in the biological program of
RhoA–transformed cells, we evaluated the invasion and adhesion properties of the cell lines
used in this study. We observed that RhoA–transformed cells displayed lower invasive rates
than the parental or the c–Myc expressing fibroblasts (Fig. 7F). However, this defective
invasiveness was rescued in RhoAQ63L/c–Myc–expressing cells (Fig. 7F). We also observed
that RhoA–expressing cells displayed enhanced adhesion to fibronectin, collagen IV,
laminin, and fibrinogen when compared to either NIH3T3 or c–Myc expressing cells (Fig.
7G). By contrast, RhoAQ63L/c–Myc–expressing cells show lower levels of adhesion to
fibronectin, collagen IV and fibrinogen when compared to RhoA–transformed cells (Fig.
7G). These data indicate that the c–Myc expression status does change at least some of the
cytoskeletal–related biological responses mediated by RhoAQ63L.
DISCUSSION
We have unveiled in this work a synergistic cross–talk between RhoAQ63L and c–Myc that,
through modification of the cellular transcriptome, promotes the disassembly of stress fibers
and focal adhesions in RhoAQ63L–transformed fibroblasts. This cross–talk entails both the
upregulation and repression of genes encoding proteins involved in cytoskeletal architecture
(i.e., integrin subunits) and regulation (i.e., Cdc42, Pak1) (Fig. 5B). This cross–talk exhibits
three remarkable features. The first of them is that the transcriptional regulation of genes
involved in this process requires synergistic signals from both RhoAQ63L and c–Myc. A
second feature is that c–Myc influences negatively the RhoA/Rock–dependent cytoskeleton
while it favors at the same time other RhoA–dependent routes essential for transformation
status of RhoAQ63L–expressing cells. This signaling specificity can be applied even within
specific branches of the Rock pathway, as inferred from the observations indicating that c–
Myc reduces the phosphorylation levels of both MLC and MYPTP1 in RhoAQ63L–
transformed cells without compromising the Rock–dependent transcriptome present in those
cells. This is probably due to the fact that Pak1 and integrins are located downstream of
Rock, a property that ensures the conservation of additional Rock downstream pathways. A
third feature of this biological program is that it can be reversed rapidly by intercellular
contacts or increased cell densities of cultured cells. Although the elucidation of this
counterbalancing pathway remains to be elucidated, our data are consistent with the
simultaneous assembly of two different regulatory steps upon the establishment of cell–cell
interactions. One of those steps relies on transcriptional–and/or mRNA stability–linked
processes, because we have found that the expression levels of Itgb1, Itbl1 and Itgb5
transcripts are restored in dense cell cultures. By contrast, another step occurs at the post–
transcriptional level since we have observed that increased cell–to–cell contacts affecs
negatively the protein levels of Pak1 while they had no effect on its mRNA levels. It is also
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possible that the establishment of extensive cell contacts could also favor indirectly stress
fiber stability by the creation of nucleation sites for the growth of F–actin cables via, for
instance, the formation of cadherin/α–catenin complexes at cell junctions.
Although counterintuitive at first sight, the negative regulation of specific downstream
branches of the RhoA/Rock pathway by c–Myc may have advantages for the overall
tumorigenic program of cancer cells. This is because this route represents a double edge
sword for cell motility. On the one hand, it ensures the sequential adhesion and detachment
of cells from the cell substrate, a process that favors cell survival, directional migration,
motility, invasiveness and extravasation processes. On the other hand, the presence of high
levels of RhoA and Rock activity can impair all those processes by favoring excessive and
static adhesion of tumor cells to the substrate or, alternatively, by inducing cell rounding and
detachment due to excessive F–actin contractility. In this functional scenario, a system that
counteracts excessive levels of RhoA and Rock activity will favor the dynamic assembly
and disassembly of stress fibers and focal adhesions. However, a system that eliminates
permanently the possibility of proper stress fiber and focal adhesion formation will also
severely impair cell motility. In this context, it is clear that a regulatory network that ensures
a regulatable and selective inhibition of the RhoA/Rock–dependent cytoskeleton will have
an obvious advantage to ensure fluid and dynamic F–actin structures and, at the same time,
maintain other RhoA–dependent functions that are important for cell growth and
tumorigenesis. Consistent with this regulatory model, we have seen that the overexpression
of c–Myc does favor a change in the invasion and adhesion properties of RhoA–transformed
cells. A foreseeable biological setting where this regulatory system could be highly
beneficial for tumor dissemination and metastasis is the case of cancer cell subtypes
associated with exacerbated signaling outputs from c–Myc and the RhoA pathway.
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MATERIALS AND METHODS
Cell lines
All NIH3T3 cell lines used in this work have been described previously (Berenjeno et al.,
2007). In that reference and the Supplementary Information linked to it online (http://
www.nature.com/onc/journal/v26/n29/suppinfo/1210194s1.html?url=/onc/journal/v2 6/n29/
full/1210194a.html), readers can also find information about the proliferative and
transforming properties of those cell lines, the culture conditions used, and the expression
levels of the proteins ectopically expressed in them. Unless otherwise stated, we used in the
experiments of this work cell lines expressing RhoAQ63L (IMB11–1–P cell line), c–Myc
(15–2–7 cell line), RhoAQ63L plus c–Myc (16–2–P3 cell line), RhoAQ63L plus MadMyc
(12–3–17 cell line) and RhoAQ63L plus a c–Myc–specific shRNA (15–6–35 cell line).
Additional information about other methods and reagents can be found in the Supplementary
Information available online.
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FIGURE 1.
c–Myc induces a reduction of stress fibers in rodent fibroblasts. (A) NIH3T3 cells
expressing the indicated molecules were fixed and stained with rhodamine–labeled
phalloidin and 4',6–diamidino–2–phenylindole (DAPI) to visualize the F–actin cytoskeleton
and nuclei, respectively. After staining, cells were analyzed by confocal microscopy. Signals
from F–actin and DAPI are shown in red and blue color, respectively. Scale bar, 20 μm.
(B,C) Flow cytometry analysis (B) and quantitation (C) of the F–actin levels present in the
indicated cell lines (n = 3). *, P ≤ 0.01 compared to parental NIH3T3 cells. (D) Expression
levels of actin (top panel) and β–tubulin (bottom panel) in total cellular extracts derived
from the indicated cells (top). In A–D, RhoAQ63L+c–Myc #1 and #2 refer to the IMB11–1–
P and IMB11–2P cell lines, respectively.
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FIGURE 2.
The loss of stress fibers in RhoAQ63L/c–Myc–expressing NIH3T3 cells is rescued by cell–
to–cell contacts. (A) NIH3T3 cells expressing the indicated ectopic proteins (top) and
derived from the indicated culture conditions (left) were stained with rhodamine–labeled
phalloidin and incubated with antibodies to vinculin to visualize F–actin fibers and focal
adhesions, respectively. Signals from F–actin and vinculin are seen in red (left columns) and
green (middle columns), respectively. Areas of co–localization between these proteins are
seen in yellow (right columns). Scale bar, 20 μm. (B) Quantitation of F– actin levels in the
indicated cell lines and culture conditions. *, P ≤ 0.01 compared to parental NIH3T3 cells.
a.u., arbitrary units.
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FIGURE 3.
c–Myc targets the Rock pathway in RhoAQ63L–transformed cells. (A) Schematic
representation of the RhoA/Rock pathway leading to actin contractility. (B) Immunoblot
analysis showing the protein expression and/or phosphorylation levels of the indicated
proteins (left) in the cell lines used in this study (top). p–, phosphorylated. RhoAQ63L+c–
Myc #1, #2 and #3 refer to the IMB11–1–P, IMB11–2P and IMB11–3P cell lines,
respectively. (C) Quantitation of phosphorylation levels of MLC (top panel) and PYPT1
(lower panel) obtained in three independent experiments. *, P ≤ 0.01 compared to parental
NIH3T3 cells. (D) Subcellular localization of p21WAF1 in the indicated cell lines (top).
Fluorescence signals derived from phalloidin–stained F–actin and the p21WAF1 antibodies
are shown in red (upper row of panels) and green (middle row of panels), respectively.
Areas of co–localization had to be seen in yellow if present (bottom row of panels). Observe
that RhoAQ63L/c–Myc expressing cells, unlike the case of RhoAQ63L–transformed cells, do
not show any cytoplasmic staining of p21WAF1. Scale bar, 20 μm.
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FIGURE 4.
Expression of RhoAQ63L or the RockII kinase domain partially rescues the stress fiber
defects present in RhoAQ63L/c–Myc–expressing NIH3T3 cells. (A,B) Cell lines expressing
the indicated proteins (top) were either transfected with a mammalian expression vector
encoding EGFP–RhoAQ63L (A) or infected with retroviruses expressing either an active (B)
or a catalytically inactive (L121G mutant) (B) version of the EGFP–RockIIKD–ER protein.
In the case of panel B, cells were either left untreated (–4–OHT) or treated (+4–OHT) with
4–OHT after the transfection, fixed, and analyzed by microscopy. Signals from EGFP fusion
proteins and F–actin are seen in red and green, respectively. Scale bars, 10 (A) and 20 (B)
μm.
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FIGURE 5.
Characterization of the transcriptomal changes present in RhoAQ63L/c–Myc–expressing
cells. (A) Hierarchical cluster diagram of the 535 genes whose expression level changed in
RhoAQ63L/MadMyc– or RhoAQ63L/MadMyc–expressing proteins relative to the
transcriptome of RhoAQ63L–transformed NIH3T3 cells. Each column represents one
experiment and each row a gene. Varying levels of expression are represented on a scale
from dark blue (lowest expression) to dark red (highest expression). Note that expression
values are represented as signal log ratio numbers and that, therefore, the total fold change
value is obtained from 2SLR. The experiment number, the cell line and the proteins
expressed in the indicated cell lines are indicated at the bottom. (B) Schematic
representation of the molecular network that can potentially interfere with RhoA signaling,
stress fibers and focal adhesions in RhoAQ63L/c–Myc–expressing cells. Transcriptionally–
regulated gene products are color–coded in red (upregulated) or blue (downregulated).
Known connections among signal transduction elements are indicated with black lanes.
Connections revealed in the present work are indicated with blue lanes. Discontinuous lanes
indicate pathways involving the participation of other signaling elements that had not been
depicted in the figure. In addition, we have also highlighted in green color proteins with
increased catalytic activity according to immunoblots analysis (see Fig. 3B,C). We have also
pin–pointed in brown color proteins and cellular structures that, according to Figs. 1–3,
show decreased activity or levels in RhoAQ63L/c–Myc–expressing cells. The participation of
the transcriptional factor E2F and Rock in the activation of the endogenous c–Myc locus has
been shown before (Berenjeno et al., 2007). For the participation of c– Myc and RhoAQ63L–
derived signals in the activation of the indicated genes, see further experiments presented in
this work (see main text, Fig. 5 and Supplementary Figure 3).
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FIGURE 6.
Corroboration of the molecular networks identified in Fig. 5B by quantitative RT–PCR. (A–
K) Relative expression levels of Cdc42 (A,G), Pak1 (B,H), Itgb1 (C,I), Itbl1 (D,J), Itgb5
(E,K), and Itgb4 (F) transcripts in the indicated cell lines (bottom) that were harvested under
low (A–F) and high density (G–K) culture conditions. Values are expressed as fold–change
of the appropriate mRNA respect to the transcript levels found in parental NIH3T3 cells (n =
3). *, P ≤ 0.01 compared to parental NIH3T3 cells.
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FIGURE 7.
Pak1 and integrin β subunits are involved in the disruption of stress fibers in RhoAQ63L/c–
Myc–expressing fibroblasts. (A) RhoAQ63L–transformed cells were infected with retroviral
particles encoding the indicated proteins (bottom) and the levels of F–actin fibers
determined (n = 3). *, P ≤ 0.01 compared to mock–infected cells. (B,C) Effect of the
overexpression of wild type Pak1 (B) and a dominant negative mutant (DNM) of Pak1 (C)
in the F–actin cytoskeleton in the indicated cell types (inset) (n = 3). #, P ≤ 0.05; *, P ≤ 0.01
compared to either mock–infected NIH3T3 (B) or mock–infected RhoAQ63L/c–Myc–
expressing (C) cells. (D) RhoA–transformed (–) or RhoAQ63L/c–Myc expressing (c–Myc+)
cells were infected with retrovirus encoding bicistronically wild type Pak1 and EGFP (+) or,
alternatively, with retroviruses containing only EGFP (–). At the indicated cell density levels
(insets), cells were fixed and F–actin levels quantified (n = 3). *, P ≤ 0.01 compared to
mock–infected RhoA–transformed cells. (E) RhoAQ63L–transformed NIH3T3 cells were
transfected with the indicated siRNAs (bottom) and, 48 h later, the levels of stress fibers
(left panel) and integrin–encoding transcripts (right panel) were evaluated by confocal
microscopy and RT–PCR, respectively (n = 3). *, P ≤ 0.01 compared to RhoA–transformed
cells transfected with the control siRNA. (F) The invasiveness of the indicated cells lines
(bottom) was determined as indicated in the Supplementary Materials and Methods (n = 3,
each performed in triplicate). *, P ≤ 0.01 compared to either parental NIH3T3 cells or the
indicated experimental subsets (brackets). (G) NIH3T3, c–Myc–, RhoAQ63L– and
RhoAQ63L/c–Myc–expressing cells (insets) were subjected to adhesion assays with the
indicated extracellular matrix proteins and control bovine serum albumin (BSA) (bottom) (n
= 3, each performed in quadruplicate). #, P ≤ 0.05; *, P ≤ 0.01 compared to either parental
NIH3T3 cells or the indicated experimental pairs (brackets). o.d., optical density.
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